Records containing: Psoriasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-19Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis
-
CLINICAL_TRIALS study record update · 2025-12-17Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS?
-
CLINICAL_TRIALS study record update · 2025-12-17Use of Transcutaneous Electrical Nerve Stimulation for Reducing Biologic Injection Site Pain
-
CLINICAL_TRIALS study record update · 2025-12-11Safety and Efficacy of Tofacitinib for Immune Skin Conditions in Down Syndrome
-
CLINICAL_TRIALS study record update · 2025-12-10Role of Reverse Transcriptase Inhibitors in the Treatment of Psoriasis: A Proof of Biological Concept Test
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-04To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Mild, Moderate Liver Impairment and Normal Liver Function After a Single Oral Administration
-
CLINICAL_TRIALS study record update · 2025-12-04To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Mild and Moderate Renal Impairment and Normal Renal Function After a Single Oral Administration
-
CLINICAL_TRIALS study record update · 2025-12-03Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets
-
CLINICAL_TRIALS study record update · 2025-12-03Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2025-12-02A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending-Dose Study of the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of XmAb27564 in Patients With Plaque Psoriasis and Atopic Dermatitis
-
CLINICAL_TRIALS study record update · 2025-12-01"DEMOS" - Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
-
CLINICAL_TRIALS study record update · 2025-11-28Phase I Comparison of Pharmacokinetics, Safety, and Immunogenicity of New Process CMAB015 Injection and Cosentyx in a Randomized, Double-blind, Parallel Controlled, Single-dose Study in Healthy Chinese Male Subjects
-
CLINICAL_TRIALS study record update · 2025-11-25Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation? Prospective Multicenter Interventional Study
-
CLINICAL_TRIALS study record update · 2025-11-25A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase 2 Study to Evaluate the Clinical Efficacy and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis
-
CLINICAL_TRIALS study record update · 2025-11-25Effects of Tildrakizumab on Coronary Microvascular Function in Moderate-Severe Psoriasis
-
CLINICAL_TRIALS study record update · 2025-11-24Investigating the Mechanisms of Short- and Long-term Responses to IL-23 Inhibition Using Tildrakizumab in Moderate to Severe Plaque Psoriasis Using High-definition Multiomics
-
CLINICAL_TRIALS study record update · 2025-11-24A Randomised Pilot Study of the Efficacy and Safety of Using Hemoperfusion With Efferon CT to Treat Patients With Severe Psoriasis
-
CLINICAL_TRIALS study record update · 2025-11-20Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis
-
CLINICAL_TRIALS study record update · 2025-11-17A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Sequential, Multiple Dose Escalation Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2025-11-10A Phase 2, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of Efficacy and Safety of SAR441566 in Adults With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2025-11-10Testing of an Educational Tool for Patients With Melanoma and Concomitant Autoimmune Disease Who Are Candidates for Adjuvant Therapy With Immune Checkpoint Inhibitors: Acceptability and Usability With Patients and Providers
-
CLINICAL_TRIALS study record update · 2025-11-03Immune Modification of Psoriasis by Selective IL-23 Blockade Using Risankizumab
-
CLINICAL_TRIALS study record update · 2025-10-24Decreasing Resident Memory T Cells While Increasing Clinical Durability: Higher Induction Doses of Risankizumab for Moderate-to-severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2025-10-20An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects With Moderate-to-Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2025-10-06Mind Matters: A High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients With Psoriatic Diseases